Introduction
Prescribing medicines for multi-morbid older adults is a challenging process, and thus potentially inappropriate prescribing (PIP) remains to be a significant problem in this patient group [1] . Across the literature, there appears to be a higher prevalence of PIP amongst hospitalised older adults compared to those who are community-dwelling [2] [3] [4] ; this is often due to medicines reconciliation issues at transitions of care, and because acutely ill older adults are usually exposed to new medicines under the care of multiple prescribers in hospital [5] . Computerised interventions have been suggested as an effective strategy to improve the appropriateness of prescribing for hospitalised older adults [4] . In the hospital setting, electronic prescribing and computerised physician order entry (CPOE) systems have been shown to reduce prescribing errors and aid in the prevention of adverse drug events (ADEs) [6, 7] .
However, no review has yet summarised the evidence regarding the impact of computerised interventions to reduce PIP in older adults specifically in the hospital setting. The primary aim of this paper was to collect all currently available evidence of prospective controlled studies that have utilised computerised interventions capable of independently identifying PIP and which aimed to improve the appropriateness of prescribing in hospitalised older adults (≥65 years). Second, we aimed to quantify the effect that these computerised interventions could have on reducing PIP in hospitalised older adults by conducting a parallel meta-analysis.
Methods
This systematic review and meta-analysis were reported in compliance with PRISMA guidelines [8] . The inclusion criteria, exclusion criteria and methods for the analysis were established in advance and documented in a protocol, which was registered with the International Prospective Register of Systematic Reviews (PROSPERO): CRD42017059795, which can be accessed from http://www.crd.york.ac.uk/ PROSPERO/display_record.asp?ID=CRD42017059795. A comprehensive electronic search of the literature was conducted using the following eight databases from inception up to and including October 2017: PubMed, EMBASE, Medline (via Ovid), Web of Science, CINAHL, Cochrane Central Register of Controlled Trials, PsycInfo and ClinicalTrials.gov. The search strategy was developed in PubMed using a combination of key words and Medical Subject Headings, as demonstrated in the Supplementary data are available in Age and Ageing online. For each of the remaining databases, the search strategy was modified to suit their specific search capabilities if necessary. Additionally, our hand search involved scrutinising the bibliographies of (i) any review papers that looked at computerised interventions in reducing PIP in older adults across different healthcare settings and (ii) all papers that were included at the full text review stage to ensure no other relevant studies were missed.
Eligibility criteria
Studies were eligible if they described a controlled intervention in which an objective was to reduce PIP in hospitalised older adults (≥65 years) using computer-generated recommendations. The primary outcomes of interest for this review were as follows: reductions in PIP or patients with PIP. The secondary outcomes of interest were patient outcomes and acceptance rates of recommendations. As determined a priori, studies involving a multifaceted intervention would be included only if the effect of the computerised intervention on reducing PIP could be clearly determined. No date or language restrictions were applied.
Study selection
For the first stage of study selection, one reviewer screened titles to eliminate papers that were clearly not relevant to the research question. Second, two reviewers independently screened titles and abstracts to identify potentially pertinent full texts. The last stage involved papers being read in full and their suitability for inclusion was determined independently by two reviewers. Two authors were contacted to supply any additional information required to decide on inclusion of the full texts [9, 10] . Consensus on inclusion was reached by discussion between reviewers, with arbitration by a senior supervisor if necessary.
Data extraction
Data extraction was performed by one reviewer and verified by another. A data extraction form was piloted on two papers and adjusted thereafter where necessary. A list of the data variables extracted can be found in the Supplementary data are available in Age and Ageing online. All authors of the included papers were contacted to provide additional data where required.
Risk of bias assessments
Two review authors independently assessed risk of bias for the included studies according to Cochrane's Effective Practice and Organisation of Care (EPOC) risk of bias criteria [11] . Consensus on the assessments was reached by discussion, with advice from a senior supervisor if required. This tool was used to determine if any of the included studies were at a high risk of bias which may impact the findings from the narrative summary or meta-analysis.
Data synthesis
Quantitative analysis was conducted if at least two studies had a common comparable outcome measure, and if pooling their results was deemed appropriate. Study heterogeneity was assessed qualitatively by reviewing the differences in the interventions and study design, whereas statistical heterogeneity was assessed using the I 2 statistic. Review Manager 5.3 was employed to determine the pooled estimate of effect and 95% confidence intervals (CIs), with P < 0.05 considered statistically significant. When it was not possible to combine outcome data due to the variability in results reporting across studies, or simply due to lack of data available, a narrative summary was provided.
Results

Search results
A total of 653 studies were identified after duplicates were removed. After the exclusion of records based on their titles and abstracts, 20 full texts were assessed for eligibility. Eight papers were suitable for inclusion in the systematic review. A PRISMA flow diagram describes the flow of studies in the review [8] and details the reasons for exclusion of full texts reviewed (Figure 1) .
Characteristics of included studies
The included studies' characteristics and outcomes are provided in Table 1 . A more detailed summary of each intervention is provided in the Supplementary data-available in Age and Ageing online. In four of the studies, the intervention utilised clinical decision support within a CPOE system [12] [13] [14] [15] . In three other studies, the intervention comprised of alerts or reminders embedded into a CPOE system [16] [17] [18] . The remaining study involved the use of INTERcheck ® software, a 'computerised prescription support system' which aimed to reduce potentially inappropriate medicines (PIMs), potentially severe drug-drug interactions and anticholinergic burden [10] . The medicines on admission were reviewed using the computerised tool and changed according to the INTERcheck ® indication. This was the only included intervention not carried out at the point of PIM prescribing. In total, there were 18,507 control patients and 24,535 intervention patients across 6 of the studies [10, 12-14, 16, 18] . One study did not report the total number of patients [17] , and the remaining study reported patient visits only [15] .
Six of the eight included studies utilised computerised alerts or reminders incorporated into a CPOE system, which appeared in various forms to notify healthcare professionals of PIP instances at the time a PIM was ordered [12, [14] [15] [16] [17] [18] . While some alerts simply provided information to the healthcare professional to guide prescribing [15, 17] , other alerts provided recommendations that required acceptance or rejection at the time a medication was ordered [12] . Five of the six studies that utilised alerts or reminders suggested an alternative to PIM use [12, 14, 15, 17, 18] . The study by Lester et al. was the exception to this; they stated that the suggested alternative may also be inappropriate for certain older patients, thus forcing the prescriber to think for themselves regarding treatment options and the health status of individual patients [16] .
Results of the risk of bias assessments
The results of the risk of bias assessments are provided in the Supplementary data-available in Age and Ageing online. All of the included studies were found to be at a low risk of bias, with one exception where the risk of bias was deemed unclear [17] . Both randomised controlled trials (RCTs) recognise that they may have been at risk of contamination [12, 14] . However, the potential for contamination in these studies, if present, would tend to bias against finding an effect of the intervention. According to Cochrane's EPOC criteria [11] , the controlled before-after studies must be deemed 'high risk' with regard to the two selection bias domains. Three of the four controlled before-after studies did not provide enough information to confirm that the baseline characteristics and outcome measurements are similar [16] [17] [18] , and thus the risk of bias was deemed 'unclear'.
Reduction in patients with PIMs
Quantitative analysis
Three of the eight studies reported the exact number of patients that were prescribed PIMs as an outcome and so were amenable to quantitative analysis [10, 14, 18] . In these three studies, there were a total of 29,791 patients/patient visits (14,860 and 14,931 in the intervention and control arms, respectively). Given the heterogeneous types of intervention and considerable statistical heterogeneity between the study results (I 2 = 82%; P = 0.004), a random-effects model was performed to provide a pooled estimate of effect. Our meta-analysis found that patients in the intervention group were less likely to be prescribed PIMs post-intervention (odds ratio 0.6, 95% CI: 0.38, 0.93) (Figure 2 ). These three studies were found to be at a low risk of bias, so we can be reasonably confident in the results of this meta-analysis.
Narrative summary
Four of the included studies reported results on the effect the intervention had on the proportion of patients prescribed PIMs, all of which showed a statistically significant reduction (P < 0.05) for this outcome [10, 14, 16, 18] . Where it was possible to calculate, there was an absolute risk reduction (ARR) of 1.3-30.1% [10, 14, 18] and a relative risk reduction (RRR) of 16.7-72.2% [10, 14, 16, 18] in patients prescribed PIMs across the studies.
Reduction in PIMs prescribed
Due to the variability in which the results were reported, a meta-analysis could not be performed for this primary outcome. Where it was possible to calculate, there was an ARR of 2-5.9% [10, 14, 15] and an RRR of 14-77.6% [10, 14, 15, 17] in PIMs prescribed across the studies. Overall, six studies showed a reduction in the number of PIMs prescribed when comparing the intervention and control groups, with five studies demonstrating statistically significant reductions (P < 0.01) [12] [13] [14] [15] 17] . The only exception to this was the study by Boustani et al., whereby the intervention group still had a greater discontinuation rate in anticholinergic drug (PIM) orders vs the control group (48.9% vs 31.2%; P = 0.11) [12] . As previously mentioned, contamination may have been an issue in this study which may have reduced the difference found between the groups. Given the overall low risk of bias in these studies, we can be reasonably confident in the results provided.
Acceptance rates of computerised recommendations
Four of the included studies have data on acceptance rates or levels of agreement with the computer's recommendations (Table 2) [13] [14] [15] 18] .
Reasons for not accepting recommendations
Three studies identified reasons why prescribers did not accept or may have overridden the computerised recommendations [13, 14, 17] . A patient having previously tolerated a PIM was the most common reason for non-acceptance of recommendations in two of the studies [13, 14] , while it remained the second most common in the remaining study after the reason that the prescriber felt that the regimen was clinically indicated Figure 2 . Forest plot for the odds ratio for the reduction in the proportion of patients prescribed PIMs post-intervention. [17] . This perhaps suggests a degree of inertia with regard to tackling PIP in the acute hospital setting.
Some of the other reasons given in these three studies included:
• On the advice of a consultant, the medicine is not to be changed [13] .
• No good substitute exists for the medication [14] .
• The patient insists on the medication [14] .
• Interaction noted, regimen clinically indicated will closely monitor [17] .
• Warning noted will use smaller dose and monitor for side effects [17] .
Clinical outcomes
Three of the included studies assessed clinical outcomes [12, 13, 15] . Griffey et al. demonstrated a statistically significant reduction in ADEs (3.4% vs 7.1%; P = 0.02) [13] and Peterson et al. showed a statistically significant reduction in inpatient falls (0.28 vs 0.64 falls per 100 patient days; P = 0.001) [15] . However, there was no statistically significant difference in the remaining 15 clinical outcomes identified, such as hospital length of stay, readmission rates or mortality rates (see Supplementary data-available in Age and Ageing online).
Discussion
This systematic review and meta-analysis show that computerised interventions can reduce PIP in hospitalised older adults. Although seven of the eight included studies showed a statistically significant reduction in PIMs ordered or the proportion of patients prescribed PIMs, it is important to note that all of these were single-centre studies. Furthermore, all the included studies in this review were conducted in the United States, except for one study conducted in Italy [10] , and therefore this may impact on the generalisability of the review findings for other countries. The acceptance rates of the computer-generated recommendations varied highly across the studies that measured this outcome (Table 2 ). These findings suggest that interventions that target a smaller number of PIP instances may have greater recommendation acceptance rates than those targeting a wider range of PIP instances. One reason for this may be that prescribers could become overwhelmed by the complexity of information provided in broader interventions [19] . It is interesting to note that Agostini et al. achieved a 95% success rate in switching to a safer alternative to a PIM, whereas only 4/53 (7.5%) recommendations for alternatives were accepted in Griffey et al. [13, 18] . Thus, providing a recommendation for an alternative does not necessarily mean that prescribers will accept this and discontinue the PIM in question. Further qualitative research is required to identify factors affecting implementation of computer-generated recommendations of this kind.
Autonomy is very important when encountering computerised interventions such as these-prescribers should be capable of bypassing recommendations where clinically appropriate [18] . While overrides are often justified, they can be associated with serious adverse events (or even death), if clinically significant information is unintentionally ignored [20] . A common reason for overrides may be due to alert fatigue, whereby prescribers may pay less attention, if they are encountering repeated or inappropriate alerts, or are being inundated by a large quantity of alerts [16, 20] . Customisation of alerts for individual institutions may improve their specificity and potentially reduce the occurrence of this phenomenon [21] .
The results of this systematic review are in keeping with that of previous reviews, which have shown that computerised interventions may be effective in improving the appropriateness of prescribing in older adults. One review assessed the use of electronic prescribing and other forms of technology in reducing PIP and polypharmacy in older adults [22] , and an older review evaluated computer decision support to improve medication prescribing in older adults [23] ; however, both studies broadly looked at interventions across different healthcare settings. This is the first systematic review to focus specifically on computerised interventions which aimed to reduce PIP for older adults in the hospital setting.
It should be noted that only two of the included studies in this review were RCTs, which are considered the most robust way of identifying if a cause-effect relationship exists between an intervention and outcome [24] . The studies included in the meta-analysis were at a low risk of bias; however, the pooled estimate of effects may have been biased as incomplete reporting in some papers meant that these were the only studies which allowed the comparison of one of the primary outcomes (data retrieval bias) [25] . Even though the other studies that assessed this outcome showed a statistically significant reduction in the proportion of patients prescribed PIMs, the pooled estimate may not accurately represent the true effect that these computerised interventions can have on reducing PIP in hospitalised older adults, especially when you consider that the metaanalysis contained studies that were not RCTs. Despite these limitations, this review is valuable for healthcare professionals as it shows that computerised interventions can be implemented in hospital settings to reduce instances of PIP for older patients. This systematic review aimed to identify computerised interventions targeting PIMs and potential prescribing omissions (PPOs). However, the included studies in this review only targeted PIMs and did not identify medication underuse, i.e. PPOs in which older patients may benefit from. Despite our comprehensive search strategy, it is still possible that all relevant papers may have not been identified. A systematic review by Meid et al. recommended that future interventions targeting PIP should utilise explicit criteria, such as Screening Tool to Alert doctors to Right Treatment (START), alone or in combination with implicit reasoning, to screen for medication underuse in older people [26] . Thus, perhaps future computerised interventions should strive to target PPOs and not just PIMs. The SENATOR (https://www.senator-project.eu/) and OPERAM (http:// operam-2020.eu/index.php?id=1488) projects are ongoing multicentre RCTs taking place in sites across Europe, which have computerised the Screening Tool of Older Persons' Prescriptions (STOPP) and START criteria as a part of their intervention [27] . These trials aim to reduce PIMs and PPOs, prevent in-hospital ADRs and reduce medicationrelated hospital admissions.
With the increasing prevalence of electronic prescribing and CPOE worldwide, it should be noted that implementing these systems does not always result in positive patient outcomes [28] . Hospital managers and other key stakeholders will have to devise strategies to allow for successful integration with clinical workflows and with other technologies already in place. All but one of the interventions in this review were conducted at the point of prescribing, which may be a key feature for designing future studies. The advantage of this is that prescribers are prompted in real time to address medication appropriateness issues to reduce the risk of ADE at the earliest possible point.
Hospital managers will also have important roles in assigning funding to these computerised systems. It has been demonstrated that the extra costs associated with the implementation of CPOE with a CDSS are acceptable in the prevention of medication errors and preventable ADEs [29] . Further research should aim to identify how best to integrate these new computerised systems into routine clinical practice and to identify methods to increase the acceptance of computer-generated recommendations, where appropriate.
Conclusions
Overall, our findings demonstrate that computerised interventions can be effective in reducing PIP in hospitalised older adults. Larger scale multicentre RCTs, at national and international levels, will be required to further demonstrate the benefit of these interventions across different institutions, ideally showing both cost-effectiveness data and clinically significant improvements in patient outcomes.
Key points
• Computerised interventions can significantly reduce the prescription of PIMs in hospitalised older adults.
• This systematic review did not identify any computerised intervention targeting medication underuse in the hospital setting.
• There is insufficient evidence to suggest that computerised interventions can routinely improve patient-related outcomes.
• Larger scale multicentre RCTs are required to establish the true impact on cost and patient-related outcomes.
• Further research must identify the factors affecting the implementation of computer-generated medication recommendations.
Supplementary data
Supplementary data mentioned in the text are available to subscribers in Age and Ageing online.
